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Abstract 
Review on t(7;9)(q11;p12) PAX5/POM121, with 
data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
B-cell acute lymphoblastic leukemia (B-ALL) 
Phenotype/cell stem origin 
Pre-B ALL (Cµ). 
Epidemiology 
Only two cases to date, 2 boys aged 1 and 2 years 
(Nebral et al., 2009; Coyaud et al., 2010). 
Prognosis 
One case was noted as high risk ALL.  
The patient remains in complete remission 20 
months after diagnosis. 
Genes involved and 
proteins 
POM121 
Location 
7q11.23 
Protein 
1249 amino acids (aa); from N-term to C-term, 
POM121 is made of a cisternal side domain (aa 1-
34), a transmembrane (Helical) domain (aa 35-55), 
and a pore side domain (aa 56-1249), and contains: 
a region for inner nuclear membrane - outer nuclear 
membrane fusion: aa 1-129, a nuclear envelope  
binding region: aa 137-265; a Pro-rich region: aa 
144-214; a Ser-rich region: aa 378-445; a Thr-rich 
region: aa 751-947; there are also phosphoserines 
aa: 345; 351; 371; 393; 5 nuclear localization 
signals (NLS): aa 321-323 (KKR); 339-342 
(KRRR); 387-390 (KRSR); 453-456 (KKIR); 504-
507 (RKRK); and xFxFG motifs (repeats based on 
cores containing Phenylalanine and Glycine (X 
denotes any amino acid) separated by linkers rich in 
serines and threonines): aa 703-707; 835-839; 861-
865; 881-885; 916-922; 994-998; 1096-1100; 1126-
1130. These FG repeats are thought to bind 
transport receptors such as importin beta and 
transportin. POM121 anchors the nuclear pore 
complex (NPC) to the nuclear envelope; the N-
terminal domain required for nuclear targeting, the 
N-terminal and transmembrane domain are required 
for NPC targeting; POM121 makes complexes with 
NUP210 (nucleoporin 210 kDa, also called GP210, 
3p25.1). Nuclear pore complexes (NPCs) assemble 
1) at the end of mitosis during nuclear envelope 
reformation (where the nuclear envelope has not 
fully formed, and NPCs are inserted into chromatin-
bound ER sheets), and 2) into an intact nuclear 
envelope during interphase when the nuclear 
envelope is completely closed and the process has 
to be coordinated across the highly organized 
structure with separated inner nuclear membrane 
and outer nuclear membrane. 
Interphase NPC formation is initiated by 
recruitment of POM121 followed by the 
incorporation of the Nup107-160 complex and 
POM121 is required for interphase NPC formation 
(the order is reverse in post-mitotic NPC formation, 
and POM121 is dispensable). 
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PAX5/POM121 protein. 
 
POM121 and SUN1 (Sad1 and UNC84 domain 
containing 1, 7p22.3) promote early steps of 
interphase NPC assembly, prior to the incorporation 
of the Nup107-160 complex (made of NUP160, 
NUP133, NUP107, NUP98, NUP85, NUP43, 
NUP37, SEC13, and SEH1L), which interacts with 
POM121. 
POM121 is required for the inner nuclear 
membrane (INM) - outer nuclear membrane fusion 
(ONM) and NPC formation.  
POM121 region aa 1-129 is sufficient to induce 
bending of the ONM and INM toward each other. 
POM121 localized to the inner nuclear membrane. 
The 5 nuclear localization signals of POM121 have 
an active role in its targeting to nuclear pore 
complexes during interphase.  
Interaction of POM121 with importin beta is 
dependent on direct binding of importin alpha to the 
nuclear localization signals of POM121.  
POM121 is transported into the nucleus through 
nuclear pores by a mechanism involving RAN 
(12q24.33) and importins and subsequently binds to 
inner nuclear membrane proteins prior to its 
incorporation into the nuclear pore complexes.  
POM121 contains a nuclear envelope-binding 
region involved in nuclear pore complex targeting. 
The nuclear envelope-binding domain is involved 
in postmitotic nuclear pore complex assembly, The 
nuclear envelope-binding region of POM121 
interacts with LBR (lamin B receptor, 1q42.12), a 
component of the inner nuclear membrane. 
The chromatin-binding protein AHCTF1 (AT hook 
containing transcription factor 1, also called ELYS, 
1q44) targets nuclear pore assembly to the surface 
of chromosomes as nuclei form at the end of 
mitosis (Koser et al., 2005; Funakoshi et al., 2011; 
Talamas and Hetzer, 2011). 
PAX5 
Location 
9p13.2 
Protein 
391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation. Entry 
of common lymphoid progenitors into the B cell 
lineage depends on E2A, EBF1, and PAX5; 
activates B-cell specific genes and repress genes 
involved in other lineage commitments. Activates 
the surface cell receptor CD19 and repress FLT3. 
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements. Genes repressed by PAX5 
expression in early B cells are restored in their 
function in mature B cells and plasma cells, and  
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PAX5 repressed (Fuxa et al., 2004; Johnson et al., 
2004; Zhang et al., 2006; Cobaleda et al., 2007; 
Medvedovic et al., 2011). 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
Fusion of PAX5 exon 5 to POM121 non coding 
exon 4. 
Fusion protein 
Description 
1288 amino acids. The predicted fusion protein 
contains the DNA binding paired domain of PAX5 
(the 201 N-term aa) and the entire 999 amino acids 
splice variant of POM121, containing most of the 
pore region of POM121. 
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